• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与颈动脉斑块形成和易损性相关的 microRNAs:临床医生的视角。

microRNAs Associated with Carotid Plaque Development and Vulnerability: The Clinician's Perspective.

机构信息

Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, św. Anny 12, 31-007 Kraków, Poland.

Department of Interventional Cardiology, The John Paul II Hospital, Prądnicka 80, 31-202 Kraków, Poland.

出版信息

Int J Mol Sci. 2022 Dec 9;23(24):15645. doi: 10.3390/ijms232415645.

DOI:10.3390/ijms232415645
PMID:36555285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9779323/
Abstract

Ischemic stroke (IS) related to atherosclerosis of large arteries is one of the leading causes of mortality and disability in developed countries. Atherosclerotic internal carotid artery stenosis (ICAS) contributes to 20% of all cerebral ischemia cases. Nowadays, atherosclerosis prevention and treatment measures aim at controlling the atherosclerosis risk factors, or at the interventional (surgical or endovascular) management of mature occlusive lesions. There is a definite lack of the established circulating biomarkers which, once modulated, could prevent development of atherosclerosis, and consequently prevent the carotid-artery-related IS. Recent studies emphasize that microRNA (miRNA) are the emerging particles that could potentially play a pivotal role in this approach. There are some research studies on the association between the expression of small non-coding microRNAs with a carotid plaque development and vulnerability. However, the data remain inconsistent. In addition, all major studies on carotid atherosclerotic plaque were conducted on cell culture or animal models; very few were conducted on humans, whereas the accumulating evidence demonstrates that it cannot be automatically extrapolated to processes in humans. Therefore, this paper aims to review the current knowledge on how miRNA participate in the process of carotid plaque formation and rupture, as well as stroke occurrence. We discuss potential target miRNA that could be used as a prognostic or therapeutic tool.

摘要

缺血性脑卒中(IS)与大动脉粥样硬化有关,是发达国家死亡和残疾的主要原因之一。动脉粥样硬化性颈内动脉狭窄(ICAS)占所有脑缺血病例的 20%。如今,动脉粥样硬化的预防和治疗措施旨在控制动脉粥样硬化的危险因素,或对成熟闭塞性病变进行介入(手术或血管内)治疗。目前明确缺乏已确定的循环生物标志物,这些标志物一旦被调节,就可以预防动脉粥样硬化的发生,从而预防与颈动脉相关的 IS。最近的研究强调,微小 RNA(miRNA)是新兴的颗粒,可能在这方面发挥关键作用。有一些关于小非编码 microRNAs 的表达与颈动脉斑块形成和易损性之间的相关性的研究。然而,数据仍然不一致。此外,所有关于颈动脉粥样硬化斑块的主要研究都是在细胞培养或动物模型上进行的;很少在人类身上进行,而越来越多的证据表明,这不能自动推断为人类体内的过程。因此,本文旨在综述 miRNA 如何参与颈动脉斑块形成和破裂以及中风发生的过程的现有知识。我们讨论了潜在的 miRNA 靶点,这些靶点可以作为预后或治疗工具。

相似文献

1
microRNAs Associated with Carotid Plaque Development and Vulnerability: The Clinician's Perspective.与颈动脉斑块形成和易损性相关的 microRNAs:临床医生的视角。
Int J Mol Sci. 2022 Dec 9;23(24):15645. doi: 10.3390/ijms232415645.
2
Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability.抑制MicroRNA-494可减少颈动脉粥样硬化病变发展并增加斑块稳定性。
Ann Surg. 2015 Nov;262(5):841-7; discussion 847-8. doi: 10.1097/SLA.0000000000001466.
3
Orosomucoid 2 as a biomarker of carotid artery atherosclerosis plaque vulnerability through its generation of reactive oxygen species and lipid accumulation in vascular smooth muscle cells.触珠蛋白 2 通过在血管平滑肌细胞中生成活性氧和脂质积累来作为颈动脉粥样硬化斑块易损性的生物标志物。
Biochem Biophys Res Commun. 2024 Apr 23;705:149736. doi: 10.1016/j.bbrc.2024.149736. Epub 2024 Feb 28.
4
MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions.MicroRNA-210 增强晚期动脉粥样硬化病变中纤维帽的稳定性。
Circ Res. 2017 Feb 17;120(4):633-644. doi: 10.1161/CIRCRESAHA.116.309318. Epub 2016 Nov 28.
5
Clinical Parameters and Epigenetic Biomarkers of Plaque Vulnerability in Patients with Carotid Stenosis.颈动脉狭窄患者斑块易损性的临床参数和表观遗传生物标志物。
Int J Mol Sci. 2022 May 5;23(9):5149. doi: 10.3390/ijms23095149.
6
Molecular Pathways of Vulnerable Carotid Plaques at Risk of Ischemic Stroke: A Narrative Review.易发生缺血性卒中的易损性颈动脉斑块的分子通路:一项叙述性综述
Int J Mol Sci. 2024 Apr 15;25(8):4351. doi: 10.3390/ijms25084351.
7
Search for Reliable Circulating Biomarkers to Predict Carotid Plaque Vulnerability.寻找可靠的循环生物标志物预测颈动脉斑块易损性。
Int J Mol Sci. 2020 Nov 3;21(21):8236. doi: 10.3390/ijms21218236.
8
Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis.抑制14q32微小RNA miR-495可减少实验性再狭窄中的病变形成、内膜增生和血浆胆固醇水平。
Atherosclerosis. 2017 Jun;261:26-36. doi: 10.1016/j.atherosclerosis.2017.04.011. Epub 2017 Apr 13.
9
Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis.基质金属蛋白酶 7 与颈动脉粥样硬化患者的症状性病变和不良事件相关。
PLoS One. 2014 Jan 6;9(1):e84935. doi: 10.1371/journal.pone.0084935. eCollection 2014.
10
The Involvement of miRNA in Carotid-Related Stroke.微小RNA在颈动脉相关中风中的作用
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1608-1617. doi: 10.1161/ATVBAHA.117.309233. Epub 2017 Aug 3.

引用本文的文献

1
Eosinophil counts predict 3-year risk of major adverse cardiovascular and cerebrovascular events in carotid artery stenosis patients.嗜酸性粒细胞计数可预测颈动脉狭窄患者发生重大心血管和脑血管不良事件的3年风险。
Sci Rep. 2025 Jul 1;15(1):20939. doi: 10.1038/s41598-025-06350-w.
2
Molecular Pathways of Vulnerable Carotid Plaques at Risk of Ischemic Stroke: A Narrative Review.易发生缺血性卒中的易损性颈动脉斑块的分子通路:一项叙述性综述
Int J Mol Sci. 2024 Apr 15;25(8):4351. doi: 10.3390/ijms25084351.
3
A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients-A Review: Part I-Epidemiology, Risk Factors, and Atherosclerosis-Related Diversities in Elderly Patients.老年患者的非冠状动脉性外周动脉粥样硬化疾病(颈动脉、肾动脉、下肢动脉)综述:第一部分——老年患者的流行病学、危险因素及与动脉粥样硬化相关的差异
J Clin Med. 2024 Mar 3;13(5):1471. doi: 10.3390/jcm13051471.
4
In-Hospital Levels of Circulating MicroRNAs as Potential Predictors of Left Ventricular Remodeling Post-Myocardial Infarction.住院期间循环 microRNAs 水平作为心肌梗死后左心室重构的潜在预测因子。
Medicina (Kaunas). 2024 Jan 13;60(1):149. doi: 10.3390/medicina60010149.
5
The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis.钠-葡萄糖共转运蛋白 2 抑制剂对亚临床动脉粥样硬化标志物的影响。
Ann Med. 2023;55(2):2304667. doi: 10.1080/07853890.2024.2304667. Epub 2024 Jan 17.
6
N-Acetylcysteine and Atherosclerosis: Promises and Challenges.N-乙酰半胱氨酸与动脉粥样硬化:前景与挑战。
Antioxidants (Basel). 2023 Dec 4;12(12):2073. doi: 10.3390/antiox12122073.
7
MicroRNA-22-3p alleviates atherosclerosis by mediating macrophage M2 polarization as well as inhibiting NLRP3 activation.microRNA-22-3p 通过调控巨噬细胞 M2 极化以及抑制 NLRP3 激活来减轻动脉粥样硬化。
J Int Med Res. 2023 Oct;51(10):3000605231197071. doi: 10.1177/03000605231197071.
8
Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis.新型治疗方法预防颈动脉粥样硬化患者的动脉粥样硬化血栓性缺血性脑卒中。
Int J Mol Sci. 2023 Sep 20;24(18):14325. doi: 10.3390/ijms241814325.
9
Cardiac microRNAs: diagnostic and therapeutic potential.心脏微小RNA:诊断和治疗潜力
Arch Med Sci. 2023 Aug 25;19(5):1360-1381. doi: 10.5114/aoms/169775. eCollection 2023.
10
Update on Biomarkers Associated with Large-Artery Atherosclerosis Stroke.大动脉粥样硬化性脑卒中相关生物标志物的研究进展。
Biomolecules. 2023 Aug 16;13(8):1251. doi: 10.3390/biom13081251.

本文引用的文献

1
Clinical Application of Serum microRNAs in Atherosclerotic Coronary Artery Disease.血清微小RNA在动脉粥样硬化性冠状动脉疾病中的临床应用
J Clin Med. 2022 Nov 20;11(22):6849. doi: 10.3390/jcm11226849.
2
MicroRNA and Hemostasis Profile of Carotid Atherosclerosis.颈动脉粥样硬化的 microRNA 和止血谱。
Int J Mol Sci. 2022 Sep 19;23(18):10974. doi: 10.3390/ijms231810974.
3
The Relationship between Selected Inflammation and Oxidative Stress Biomarkers and Carotid Intima-Media Thickness (IMT) Value in Youth with Type 1 Diabetes Co-Existing with Early Microvascular Complications.1型糖尿病合并早期微血管并发症青年患者中选定的炎症和氧化应激生物标志物与颈动脉内膜中层厚度(IMT)值之间的关系
J Clin Med. 2022 Aug 13;11(16):4732. doi: 10.3390/jcm11164732.
4
Diagnostic and Prognostic Value Analysis of miR-206 in Asymptomatic Carotid Artery Stenosis.miR-206 在无症状性颈动脉狭窄中的诊断及预后价值分析。
Br J Biomed Sci. 2022 Jul 6;79:10592. doi: 10.3389/bjbs.2022.10592. eCollection 2022.
5
Emerging Role of Non-Coding RNAs in Senescence.非编码RNA在衰老中的新兴作用。
Front Cell Dev Biol. 2022 Jul 5;10:869011. doi: 10.3389/fcell.2022.869011. eCollection 2022.
6
Therapeutic Response of miR-145 Micelles on Patient-Derived Vascular Smooth Muscle Cells.miR-145 胶束对患者来源的血管平滑肌细胞的治疗反应
Front Digit Health. 2022 Jun 15;4:836579. doi: 10.3389/fdgth.2022.836579. eCollection 2022.
7
Vascular Alterations Preceding Arterial Wall Thickening in Overweight and Obese Children.超重和肥胖儿童动脉壁增厚之前的血管改变
J Clin Med. 2022 Jun 19;11(12):3520. doi: 10.3390/jcm11123520.
8
Serum and Vascular Stiffness Biomarkers Associated with the Severity of Degenerative Aortic Valve Stenosis and Cardiovascular Outcomes.与退行性主动脉瓣狭窄严重程度及心血管结局相关的血清和血管僵硬度生物标志物
J Cardiovasc Dev Dis. 2022 Jun 17;9(6):193. doi: 10.3390/jcdd9060193.
9
A new approach of statin therapy in carotid atherosclerosis: Targeting indices of plaque vulnerability on the top of lipid-lowering. A narrative review.他汀类药物治疗颈动脉粥样硬化的新方法:在降脂基础上靶向斑块易损性指标。一篇叙述性综述。
Kardiol Pol. 2022;80(9):880-890. doi: 10.33963/KP.a2022.0155. Epub 2022 Jun 23.
10
Clinical Values and Underlying Mechanism Analysis of Serum miR-455-5p in Carotid Artery Stenosis.血清miR-455-5p在颈动脉狭窄中的临床价值及潜在机制分析
J Inflamm Res. 2022 May 30;15:3207-3217. doi: 10.2147/JIR.S362774. eCollection 2022.